Condition

Inflammatory bowel disease

Broader IBD news covering Crohn's disease, ulcerative colitis, research, treatments, monitoring, and patient care.

Page 48 of 48 · 2295 articles

Trethera Announces Inflammatory Bowel Disease Poster Presentation at the Annual Crohn’s & Colitis Foundation Congress
markets.businessinsider.com

Trethera Announces Inflammatory Bowel Disease Poster Presentation at the Annual Crohn’s & Colitis Foundation Congress

Patients with Crohn’s disease and other IBD forms may see new research directions aimed at blocking immune cell proliferation by targeting nucleotide metabolism. This is early-stage, preclinical work presented at a...

Read Summary
RS-1805 by Reistone Biopharma for Crohn’s Disease (Regional Enteritis): Likelihood of Approval
pharmaceutical-technology.com

RS-1805 by Reistone Biopharma for Crohn’s Disease (Regional Enteritis): Likelihood of Approval

Cure8 found this source from pharmaceutical-technology.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original...

Read Summary
Amelenodor by AbbVie for Crohn’s Disease (Regional Enteritis): Likelihood of Approval
pharmaceutical-technology.com

Amelenodor by AbbVie for Crohn’s Disease (Regional Enteritis): Likelihood of Approval

This notes a new oral investigational drug (Amelenodor/NX-13) in Phase I for Crohn’s and ulcerative colitis and highlights industry predictions about its chances of advancing. People with IBD may want to know about...

Read Summary